Literature DB >> 28506748

Copy number variation analysis of patients with intellectual disability from North-West Spain.

Inés Quintela1, Jesús Eirís2, Carmen Gómez-Lado2, Laura Pérez-Gay3, David Dacruz2, Raquel Cruz4, Manuel Castro-Gago2, Luz Míguez5, Ángel Carracedo6, Francisco Barros7.   

Abstract

Intellectual disability (ID) is a complex and phenotypically heterogeneous neurodevelopmental disorder characterized by significant deficits in cognitive and adaptive skills, debuting during the developmental period. In the last decade, microarray-based copy number variation (CNV) analysis has been proved as a strategy particularly useful in the discovery of loci and candidate genes associated with these phenotypes and is widely used in the clinics with a diagnostic purpose. In this study, we evaluated the usefulness of two genome-wide high density SNP microarrays -Cytogenetics Whole-Genome 2.7M SNP array (n=126 patients; Group 1) and CytoScan High-Density SNP array (n=447 patients; Group 2)- in the detection of clinically relevant CNVs in a cohort of ID patients from Galicia (NW Spain). In 159 (27.7%) patients, we detected 186 rare exonic chromosomal imbalances, that were grouped into the following classes: Clinically relevant (67/186; 36.0%), of unknown clinical significance (93/186; 50.0%) and benign (26/186; 14.0%). The 67 pathogenic CNVs were identified in 64 patients, which means an overall diagnostic yield of 11.2%. Overall, we confirmed that ID is a genetically heterogeneous condition and emphasized the importance of using genome-wide high density SNP microarrays in the detection of its genetic causes. Additionally, we provided clinical and molecular data of patients with pathogenic or likely pathogenic CNVs and discussed the potential implication in neurodevelopmental disorders of genes located within these variants.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism spectrum disorder; Chromosome microarray analysis; Diagnostic yield; Global developmental delay; SNP microarray

Mesh:

Year:  2017        PMID: 28506748     DOI: 10.1016/j.gene.2017.05.032

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Critical evaluation of copy number variant calling methods using DNA methylation.

Authors:  Varun Kilaru; Anna K Knight; Seyma Katrinli; Dawayland Cobb; Adriana Lori; Charles F Gillespie; Adam X Maihofer; Caroline M Nievergelt; Anne L Dunlop; Karen N Conneely; Alicia K Smith
Journal:  Genet Epidemiol       Date:  2019-11-18       Impact factor: 2.135

2.  Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers.

Authors:  Akif Ayaz; Alper Gezdirici; Elif Yilmaz Gulec; Ozge Ozalp; Abdullah Huseyin Koseoglu; Zeynep Dogru; Sinem Yalcintepe
Journal:  Medeni Med J       Date:  2022-06-23

3.  Yield of comparative genomic hybridization microarray in pediatric neurology practice.

Authors:  Shibalik Misra; Greg Peters; Elizabeth Barnes; Simone Ardern-Holmes; Richard Webster; Christopher Troedson; Shekeeb S Mohammad; Deepak Gill; Manoj Menezes; Sachin Gupta; Peter Procopis; Jayne Antony; Manju A Kurian; Russell C Dale
Journal:  Neurol Genet       Date:  2019-10-23

4.  Testing single/combined clinical categories on 5110 Italian patients with developmental phenotypes to improve array-based detection rate.

Authors:  Ilaria Catusi; Maria Paola Recalcati; Ilaria Bestetti; Maria Garzo; Chiara Valtorta; Melissa Alfonsi; Alberta Alghisi; Stefania Cappellani; Rosario Casalone; Rossella Caselli; Caterina Ceccarini; Carlo Ceglia; Anna Maria Ciaschini; Domenico Coviello; Francesca Crosti; Annamaria D'Aprile; Antonella Fabretto; Rita Genesio; Marzia Giagnacovo; Paola Granata; Ilaria Longo; Michela Malacarne; Giuseppina Marseglia; Annamaria Montaldi; Anna Maria Nardone; Chiara Palka; Vanna Pecile; Chiara Pessina; Diana Postorivo; Serena Redaelli; Alessandra Renieri; Chiara Rigon; Fabiola Tiberi; Mariella Tonelli; Nicoletta Villa; Anna Zilio; Daniela Zuccarello; Antonio Novelli; Lidia Larizza; Daniela Giardino
Journal:  Mol Genet Genomic Med       Date:  2019-12-18       Impact factor: 2.183

5.  Nanoplasmonic immunosensor for the detection of SCG2, a candidate serum biomarker for the early diagnosis of neurodevelopmental disorder.

Authors:  So-Hee Lim; Yun-Ju Sung; Narae Jo; Na-Yoon Lee; Kyoung-Shim Kim; Da Yong Lee; Nam-Soon Kim; Jeehun Lee; Ju-Young Byun; Yong-Beom Shin; Jae-Ran Lee
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

6.  Differences in the importance of microcephaly, dysmorphism, and epilepsy in the detection of pathogenic CNVs in ID and ASD patients.

Authors:  Zuzana Capkova; Pavlina Capkova; Josef Srovnal; Katerina Staffova; Vera Becvarova; Marie Trkova; Katerina Adamova; Alena Santava; Vaclava Curtisova; Marian Hajduch; Martin Prochazka
Journal:  PeerJ       Date:  2019-11-15       Impact factor: 2.984

Review 7.  Variable Phenotypes of Epilepsy, Intellectual Disability, and Schizophrenia Caused by 12p13.33-p13.32 Terminal Microdeletion in a Korean Family: A Case Report and Literature Review.

Authors:  Ji Yoon Han; Joonhong Park
Journal:  Genes (Basel)       Date:  2021-06-29       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.